HMGB1 and neoplasm: These agents promote the release of tumor antigens in conjunction with the release of signals that activate APCs, including ATP, high mobility group box-1 (HMGB1) and interferon-β (IFNβ), and the exposure of calreticulin on the surface of tumor cells 5.